Soreide Law Group has received calls from clients who purchased Affimed N.V., symbol (AFMD). This security was offered by Laidlaw and Company, who also served as the underwriter of the offering.
According to some of the facts on Yahoo Finance, Affimed N.V. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing cancer immunotherapies in Germany and internationally. It also has a clinical development and commercialization collaboration with The University of Texas MD Anderson Cancer Center. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.
AFMD was trading in September of 2014 around 6.30, the stock hit approximately 16.41 in July of 2015, and now is trading today around 2.42.
If you invested in Affimed N.V. (AFMD) through a recommendation of a Laidlaw and Company securities broker and you experienced losses due to the recommendation, call Soreide Law Group for a free consultation with an experienced securities lawyer regarding the possible recovery of your investment losses through a FINRA arbitration at: 888-760-6552.
Soreide Law Group represents clients nationwide before FINRA. We operate on a contingency fee basis, no fee if no recovery.
The recent Chapter 11 bankruptcy filing by Inspired Healthcare Capital (IHC) has sent shockwaves through the senior living investment community. For many retirees and 1031 exchange participants, what was marketed as a stable, income-producing real estate opportunity has turned into a complex legal battle for recovery. If you invested in an IHC-sponsored Delaware Statutory Trust […]
Soreide Law Group is investigating potential investor claims involving NLCA VA Birmingham Realty DST, particularly where brokers or financial advisors may have improperly recommended this specific Delaware Statutory Trust offering. NLCA VA Birmingham Realty DST is a 1031 exchange investment vehicle that offered investors fractional interests in real estate through a private placement. Although it […]
Investors have reportedly disputed the sales practices of securities broker Nicholas Cross Ignatowski (also known as Nick Ignatowski) [CRD: 2409399, Milwaukee, Wisconsin], based on publicly available information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Ignatowski worked for LPL Financial LLC from August 20, 2013, to December 31, 2023. Investors are encouraged to continue reading […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com